Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

NCT01578668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Lung Adenocarcinoma
Brain Metastases

Interventions

DRUG: erlotinib
DRUG: pemetrexed
DRUG: cisplatin
DRUG: erlotinib

Sponsor

Guangzhou Medical University